6533b855fe1ef96bd12affd9
RESEARCH PRODUCT
Flow cytometric assay for estimating fungicidal activity of Amphotericin B in human serum
Ute SchlasiusSucharit BhakdiE Martinsubject
Microbiology (medical)ImmunologyColony Count MicrobialBiologyPharmacologyMicrobiologyFlow cytometrychemistry.chemical_compoundAmphotericin BAmphotericin BCandida albicansmedicineHumansImmunology and AllergyBioassayPropidium iodideCandida albicansmedicine.diagnostic_testCandidiasisGeneral MedicineFungi imperfectiFlow Cytometrybiology.organism_classificationFungicidechemistryEx vivomedicine.drugdescription
We describe a simple and rapid bioassay for estimating fungicidal activity of Amphotericin B in human serum using flow cytometry. The method exploits the fact that Candida albicans damaged by Amphotericin B show a decrease in size and take up propidium iodide to exhibit a red fluorescence after deoxycholate treatment. These phenomena display characteristic dose dependencies, and their assessment permits serum fungicidal activity to be broadly grouped into three categories: (1) subfungicidal; (2) fungicidal; and (3) strongly fungicidal. In normal human serum, these three categories correspond to Amphotericin B concentrations of 0 less than or equal to 0.5 micrograms/ml, 0.75-1.5 micrograms/ml, and greater than 2 micrograms/ml, respectively. Pilot analysis of serum samples obtained from four patients undergoing Amphotericin B therapy confirmed the feasibility of using the flow cytometric assay for estimating drug fungicidal activity ex vivo. The method is very simple, generates results within 5 h, and could prove useful for monitoring therapy with this effective but toxic drug.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 1992-07-01 | Medical Microbiology and Immunology |